HUT63567A - Process for producing composition suitable for treating infections caused by organisms sensitive to beta-lactam antibiotics - Google Patents

Process for producing composition suitable for treating infections caused by organisms sensitive to beta-lactam antibiotics

Info

Publication number
HUT63567A
HUT63567A HU922720A HU272092A HUT63567A HU T63567 A HUT63567 A HU T63567A HU 922720 A HU922720 A HU 922720A HU 272092 A HU272092 A HU 272092A HU T63567 A HUT63567 A HU T63567A
Authority
HU
Hungary
Prior art keywords
beta
composition suitable
infections caused
lactam antibiotics
treating infections
Prior art date
Application number
HU922720A
Other languages
English (en)
Other versions
HU9202720D0 (en
Inventor
Richard P Darveau
James J Blake
Wesley L Cosand
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HU9202720D0 publication Critical patent/HU9202720D0/hu
Publication of HUT63567A publication Critical patent/HUT63567A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HU922720A 1990-02-23 1991-02-25 Process for producing composition suitable for treating infections caused by organisms sensitive to beta-lactam antibiotics HUT63567A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48402090A 1990-02-23 1990-02-23
US65532191A 1991-02-19 1991-02-19
OA59988A OA10059A (en) 1990-02-23 1991-04-12 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics

Publications (2)

Publication Number Publication Date
HU9202720D0 HU9202720D0 (en) 1992-12-28
HUT63567A true HUT63567A (en) 1993-09-28

Family

ID=33314051

Family Applications (1)

Application Number Title Priority Date Filing Date
HU922720A HUT63567A (en) 1990-02-23 1991-02-25 Process for producing composition suitable for treating infections caused by organisms sensitive to beta-lactam antibiotics

Country Status (14)

Country Link
US (1) US5409898A (hu)
EP (1) EP0516747A4 (hu)
JP (1) JPH05506645A (hu)
CN (1) CN1054900A (hu)
AU (1) AU650262B2 (hu)
CA (1) CA2076529A1 (hu)
CZ (1) CZ47791A3 (hu)
FI (1) FI923747A (hu)
HU (1) HUT63567A (hu)
IE (1) IE910630A1 (hu)
IL (1) IL97344A (hu)
NZ (1) NZ237202A (hu)
OA (1) OA10059A (hu)
WO (1) WO1991012815A1 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613734B2 (en) * 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
WO1996035804A1 (en) * 1995-05-08 1996-11-14 Merck & Co., Inc. A novel biochemical interaction in bacteria
US5747453A (en) * 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6180604B1 (en) 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
NL1008139C2 (nl) * 1998-01-27 1999-07-28 Stichting Tech Wetenschapp Antimicrobiële peptiden.
AU2683699A (en) 1998-02-18 1999-09-06 Harbor-Ucla Research And Education Institute Antimicrobial peptides and derived metapeptides
US7820619B1 (en) * 1998-02-18 2010-10-26 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Antimicrobial peptides and derived metapeptides
US6191168B1 (en) 1998-06-02 2001-02-20 Edward Rubenstein Methods for the use of nonprotein amino acids as therapeutic agents
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
AU2002328203C1 (en) 2001-08-24 2009-01-08 Migenix Inc. Antimicrobial and anti-inflammatory peptides
WO2003092597A2 (en) 2002-05-01 2003-11-13 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
CN101232881A (zh) * 2005-07-27 2008-07-30 惠氏公司 双环6-亚烷基-青霉烯B-内酰胺酶抑制剂与β-内酰胺抗生素的组合：广谱抗生素
EP2536408A1 (en) * 2010-02-16 2012-12-26 Wockhardt Research Centre Efflux pump inhibitors
SG191716A1 (en) 2010-11-19 2013-08-30 Toshio Imai Neutralizing anti-ccl20 antibodies
CN107320727A (zh) * 2016-04-29 2017-11-07 四川大学 抗菌肽与抗生素组合抗菌药物及其使用方法
US20230414719A1 (en) * 2020-11-09 2023-12-28 Arizona Board Of Regents On Behalf Of Arizona State University Methods of using platelet factor 4 as an antimicrobial agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins

Also Published As

Publication number Publication date
EP0516747A4 (en) 1993-03-24
CN1054900A (zh) 1991-10-02
AU650262B2 (en) 1994-06-16
IE910630A1 (en) 1991-08-28
IL97344A0 (en) 1992-05-25
EP0516747A1 (en) 1992-12-09
CA2076529A1 (en) 1991-08-24
AU7485691A (en) 1991-09-18
OA10059A (en) 1996-10-14
FI923747A0 (fi) 1992-08-20
HU9202720D0 (en) 1992-12-28
US5409898A (en) 1995-04-25
JPH05506645A (ja) 1993-09-30
IL97344A (en) 1995-12-31
FI923747A (fi) 1992-08-20
WO1991012815A1 (en) 1991-09-05
NZ237202A (en) 1994-01-26
CZ47791A3 (en) 1993-04-14

Similar Documents

Publication Publication Date Title
HUT63567A (en) Process for producing composition suitable for treating infections caused by organisms sensitive to beta-lactam antibiotics
HU910620D0 (en) Process for producing carbapenem derivatives having antibiotic effect
HUT35273A (en) Process for preparing epimeric azaerythromycin a derivatives and intermediary products thereof
EP0444640A3 (en) Process for biological production of organic acids
HU911132D0 (en) Process for producing carbapenem compounds
HUT58338A (en) Process for producing macrolide compounds
HU9201301D0 (en) Process for the microbiological aerobic decomposition of biological materials with increased speed
YU42802B (en) Process for producing beta-lactam antibiotics
EP0464582A3 (en) Process for the purification of riboflavin obtained by fermentation
HUT62453A (en) Process for producing pour-on composition with vermicidal effect
EP0482909A3 (en) Process for producing antibiotics
IL99513A0 (en) Process for the preparation of carbapenem compounds
EP0444708A3 (en) Process for preparation of beta-lactam derivatives
EP0466042A3 (en) Microbiological process for the oxidation of methyl groups
HUT58522A (en) Process for producing pharmaceutical compositions suitable for treating allergic conjunctivitis
GB9113108D0 (en) Improved process for production of an antibiotic compound
HU9200728D0 (en) Process for the production of 1-lizin by fermentation
YU143580A (en) Process for producing antibiotic compounds
CS517290A3 (en) Process for preparing cortalceron antibiotic by enzyme transformation ofd-glucose or d-glucosan
ZA911347B (en) Compositions and methods for treating infections caused by organisms sensitive to"-lactam antibiotics
HU912008D0 (en) Process for the improving of organic compounds
HU911596D0 (en) Process for producing carbapeneme derivatives of antibiotic effect
HU913187D0 (en) Process for the production of antibiotic preparation
HU911873D0 (en) Process for producing antibiotic
HU905869D0 (en) Process for producing antibiotic

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal